期刊文献+

子宫内膜癌126例临床病理与预后分析 被引量:10

A clinicopathologic and prognostic analysis of 126 cases of endometrial carcinoma
下载PDF
导出
摘要 目的:探讨子宫内膜癌的临床、病理特点及影响预后的因素。方法:回顾分析了2000年1月至2004年12月5年间山东大学齐鲁医院收治的126例子宫内膜癌患者的临床资料。结果:126例子宫内膜癌患者平均发病年龄53.5岁,获得随访的113例患者3年生存率为85.7%,5年生存率为75.1%,总体生存率为69.7%。多因素分析结果显示,手术病理分期(P=0.009)、组织学分级(P=0.006)、淋巴结转移(P=0.025)、病理类型(P=0.001)与预后显著相关,是影响子宫内膜癌患者总体生存率的独立因素。结论:子宫内膜癌手术病理分期、组织学分级、淋巴结转移、病理类型和预后有显著相关性,是影响患者总体生存率的独立因素。 Objective:To explore the clinicopathologic character for endometrial carcinoma and prognostic factors.Methods:One hundred and twenty-six patients with endometrial carcinoma accepted primary surgical treatment from Jan.2000 to Dec.2004 at Qilu Hospital of Shandong University were analyzed retrospectively.Results:The average age of 126 patients was 53.5 years.The 3-year and 5-year survival rate of 113 patients were 85.7% and 75.1%.The overall survival rate were 69.7%.Prognostic factors were also analysed by the multivariate Cox proportional-hazard model.Forward stepwise elimination according to Cox regression results led to a model containing four independent terms that were predictive of overall survival:FIGO surgical stage(P=0.009),histological grade(P=0.006),lymph node involvement(P=0.025),histological type(P=0.001).Conclusion:The FIGO surgical stage,histological grade,lymph node involvement and histological type of endometrial carcinoma are able to assess prognosis objectively.
出处 《现代妇产科进展》 CSCD 北大核心 2011年第10期799-802,共4页 Progress in Obstetrics and Gynecology
关键词 子宫内膜癌 肿瘤分期 病理 肿瘤转移 预后 Endometrial neoplasm Neoplasm staging Pathology neoplasm metastasis Prognosis
  • 相关文献

参考文献17

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008 [J]. CA Cancer J Clin,2008 ,58 :71-96.
  • 2连利娟.林巧稚妇科肿瘤学[M].第3版.北京:人民卫生出版社.2001.184.
  • 3Zusterzeel PL, Bekkers RL, Hendriks JC, et al. Prognostic factors for recurrence in patients with FIGO stage I and Ⅱ , intermediate or high risk endometrial cancer [ J ]. Acta Obstet Gynecol Scand ,2008,87 (2) :240-246.
  • 4Gadducci A, Cavazzana A, Cosio S, et al. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage Ⅰ- Ⅱ endometrioid-type endometrial cancer [ J ]. Anticancer Res, 2009,29 ( 5 ) : 1715-1720.
  • 5Banno K, Yanokura M, Kobayashi Y, et al. Endometrial cancer as a familial tumor:pathology and molecular carci- nogenesis (review) [ J ]. Curr Genomics, 2009,10 ( 2 ) : 127-132.
  • 6Takeshima N, Ota T, Omatsu K, et al. Postoperative adju- vant chemotherapy in surgically staged grade 3 endometri- al cancer[ J]. Anticancer Res ,2008,28 (3B) : 1785-1788.
  • 7曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2003:2578.
  • 8Mundt AJ, Connell PP. Do conventional pathologic fea- tures lose their prognostic significance following postoper- ative radiation therapy in pathologic stage Ⅰ - Ⅱ endome- trial adenocarcinoma [ J ]. Int J Cancer, 2000,90 ( 4 ) : 224-230.
  • 9Morrow CP, Bundy BN, Kurman RJ, et al. Relationship be- tween surgical- pathological risk factors and outcome in clinical stage Ⅰ and Ⅱ carcinoma of the endometrium:a Gynecologic Oncology Group study [ J ]. Gynecol Oncol, 1991,40( 1 ) :55-65.
  • 10American Cancer Society. Cancer Facts and Figures 2007, Uterine Corpus ( endometrium ) [ R ]. Atlanta : A- merican Cancer Society,2007:21-21.

共引文献152

同被引文献86

  • 1李斌,吴令英,李淑敏,章文华,张蓉,马绍康.子宫内膜癌的预后影响因素分析[J].癌症,2004,23(9):1085-1088. 被引量:31
  • 2Zusterzeel PL,Bekkers RL,Hendriks JC,et al.Prognostic factors for recur-rence in patients with FIGO stage I andⅡ,intermediate or high risk endom-etrial cancer[J].Acta Obstet Gynecol Scand,2008;87(2):240-6.
  • 3JemalA, SiegelR, WardE, et al. Cancer statistics, 2008 [J]. CA Cancer J Clin, 2008, 58 (2): 71-96.
  • 4Ambros IRA, Kurman RJ. Idenitification of patients with stage I uterine en- dometeioid adenocarcinoma at hight risk of recurrence by DNA ploidy, myometrial invasion and vascular invation [J]. Gynecol Oncol, 1992, 45 (3) : 235 -239.
  • 5Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer [J]. Int J Gynaeeol Obsetet, 2006, 95 Suppl 1 : S105 -S143.
  • 6Geislcr JP, Linnemeier GC, Manahan KI. Pelvic and para - aortic lymph- adenectomy in patients with endometrioid adenocaeeinoma of the endometrium [ J]. lnt J Gynecold Obster, 2007, 98:39-43.
  • 7Siegel R,Naishadham D,Jemal A. Cancer statistics,2013 [ Jl. CA Cancer J Clin, 2013, 63:11-30.
  • 8Nicanor I, Barrena M, Thomas JH, et al. Comparison of the pro- gonostic significance of uterine factor and nodal status for endom- etrial cancer [ J]. Am J Obstet Gynecol, 2011, 204:248.
  • 9Jayakrishnan K, Anupama R. Endometrial carcinoma in a young subfertile woman with polycystic ovarian syndrome [ J ]. J Hum Reprod Sci, 2010, 3:38-41.
  • 10Odagiri T, Watari H, Hosaka M, et al. Multivariate survival anal- ysis of the patients with recurrent endometrial cancer[J]. Gyne- eol Oncol, 2011, 22:3-8.

引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部